|
1
|
McGuckin MA, Linden SK, Sutton P and
Florin TH: Mucin dynamics and enteric pathogens. Nat Rev Microbiol.
9:265–278. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jonckheere N, Skrypek N and Van Seuningen
I: Mucins and tumor resistance to chemotherapeutic drugs. Biochim
Biophys Acta. 1846:142–151. 2014.PubMed/NCBI
|
|
3
|
Kufe DW: Mucins in cancer: Function,
prognosis and therapy. Nat Rev Cancer. 9:874–885. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Shimamura T, Ito H, Shibahara J, Watanabe
A, Hippo Y, Taniguchi H, Chen Y, Kashima T, Ohtomo T, Tanioka F, et
al: Overexpression of MUC13 is associated with intestinal-type
gastric cancer. Cancer Sci. 96:265–273. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Walsh MD, Young JP, Leggett BA, Williams
SH, Jass JR and McGuckin MA: The MUC13 cell surface mucin is highly
expressed by human colorectal carcinomas. Hum Pathol. 38:883–892.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gupta BK, Maher DM, Ebeling MC, Sundram V,
Koch MD, Lynch DW, Bohlmeyer T, Watanabe A, Aburatani H, Puumala
SE, et al: Increased expression and aberrant localization of mucin
13 in metastatic colon cancer. J Histochem Cytochem. 60:822–831.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gupta BK, Maher DM, Ebeling MC, Stephenson
PD, Puumala SE, Koch MR, Aburatani H, Jaggi M and Chauhan SC:
Functions and regulation of MUC13 mucin in colon cancer cells. J
Gastroenterol. 49:1378–1391. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Khan S, Ebeling MC, Zaman MS, Sikander M,
Yallapu MM, Chauhan N, Yacoubian AM, Behrman SW, Zafar N, Kumar D,
et al: MicroRNA-145 targets MUC13 and suppresses growth and
invasion of pancreatic cancer. Oncotarget. 5:7599–7609. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chauhan SC, Ebeling MC, Maher DM, Koch MD,
Watanabe A, Aburatani H, Lio Y and Jaggi M: MUC13 mucin augments
pancreatic tumorigenesis. Mol Cancer Ther. 11:24–33. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sheng Y, Ng CP, Lourie R, Shah ET, He Y,
Wong KY, Seim I, Oancea I, Morais C, Jeffery PL, et al: MUC13
overexpression in renal cell carcinoma plays a central role in
tumor progression and drug resistance. Int J Cancer. 140:2351–2363.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chauhan SC, Vannatta K, Ebeling MC,
Vinayek N, Watanabe A, Pandey KK, Bell MC, Koch MD, Aburatani H,
Lio Y and Jaggi M: Expression and functions of transmembrane mucin
MUC13 in ovarian cancer. Cancer Res. 69:765–774. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Linden SK, Sutton P, Karlsson NG, Korolik
V and McGuckin MA: Mucins in the mucosal barrier to infection.
Mucosal Immunol. 1:183–197. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sheng YH, Lourie R, Linden SK, Jeffery PL,
Roche D, Tran TV, Png CW, Waterhouse N, Sutton P, Florin TH and
McGuckin MA: The MUC13 cell-surface mucin protects against
intestinal inflammation by inhibiting epithelial cell apoptosis.
Gut. 60:1661–1670. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Williams SJ, Wreschner DH, Tran M, Eyre
HJ, Sutherland GR and McGuckin MA: Muc13, a novel human cell
surface mucin expressed by epithelial and hemopoietic cells. J Biol
Chem. 276:18327–18336. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sheng YH, He Y, Hasnain SZ, Wang R, Tong
H, Clarke DT, Lourie R, Oancea I, Wong KY, Lumley JW, et al: MUC13
protects colorectal cancer cells from death by activating the NF-κB
pathway and is a potential therapeutic target. Oncogene.
36:700–713. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sheng YH, Triyana S, Wang R, Das I,
Gerloff K, Florin TH, Sutton P and McGuckin MA: MUC1 and MUC13
differentially regulate epithelial inflammation in response to
inflammatory and infectious stimuli. Mucosal Immunol. 6:557–568.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Naccarati A, Pardini B, Hemminki K and
Vodicka P: Sporadic colorectal cancer and individual
susceptibility: A review of the association studies investigating
the role of DNA repair genetic polymorphisms. Mutat Res.
635:118–145. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tomlinson IP, Dunlop M, Campbell H, Zanke
B, Gallinger S, Hudson T, Koessler T, Pharoah PD, Niittymäki I,
Tuupanen S, et al: COGENT (COlorectal cancer GENeTics): An
international consortium to study the role of polymorphic variation
on the risk of colorectal cancer. Br J Cancer. 102:447–454. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Rattray NJW, Charkoftaki G, Rattray Z,
Hansen JE, Vasiliou V and Johnson CH: Environmental influences in
the etiology of colorectal cancer: The premise of metabolomics.
Curr Pharmacol Rep. 3:114–125. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhao Y, Zhang W, Huo M, Wang P, Liu X,
Wang Y, Li Y, Zhou Z, Xu N and Zhu H: XBP1 regulates the protumoral
function of tumor-associated macrophages in human colorectal
cancer. Signal Transduct Target Ther. 6:3572021. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Vymetalkova V, Pardini B, Rosa F,
Jiraskova K, Di Gaetano C, Bendova P, Levy M, Veskrnova V, Buchler
T, Vodickova L, et al: Polymorphisms in microRNA binding sites of
mucin genes as predictors of clinical outcome in colorectal cancer
patients. Carcinogenesis. 38:28–39. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Brenner H, Kloor M and Pox CP: Colorectal
cancer. Lancet. 383:1490–1502. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2020. CA Cancer J Clin. 70:7–30. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hao M, Wang K, Ding Y, Li H, Liu Y and
Ding L: Which patients are prone to suffer liver metastasis? A
review of risk factors of metachronous liver metastasis of
colorectal cancer. Eur J Med Res. 27:1302022. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Krizkova V, Dubova M, Susova S, Vycital O,
Bruha J, Skala M, Liska V, Daum O and Soucek P: Protein expression
of ATP-binding cassette transporters ABCC10 and ABCC11 associates
with survival of colorectal cancer patients. Cancer Chemother
Pharmacol. 78:595–603. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Witter K, Tonar Z, Matejka VM, Martinca T,
Jonák M, Rokosný S and Pirk J: Tissue reaction to three different
types of tissue glues in an experimental aorta dissection model: A
quantitative approach. Histochem Cell Biol. 133:241–259. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Eberlová L, Tonar Z, Witter K, Křížková V,
Nedorost L, Korabečná M, Tolinger P, Kočová J, Boudová L, Třeška V,
et al: Asymptomatic abdominal aortic aneurysms show histological
signs of progression: A quantitative histochemical analysis.
Pathobiology. 80:11–23. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Cervena K, Novosadova V, Pardini B,
Naccarati A, Opattova A, Horak J, Vodenkova S, Buchler T, Skrobanek
P, Levy M, et al: Analysis of MicroRNA expression changes during
the course of therapy in rectal cancer patients. Front Oncol.
11:7022582021. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Guru SA, Sumi MP, Najar IA, Mir AR and
Saxena A: MO10-6 miR-4647 an early biomarker of outcome in chronic
myeloid leukaemia patients. Ann Oncol. 33 (Suppl 6):S4882022.
View Article : Google Scholar
|
|
31
|
Liu C, Rennie WA, Carmack CS, Kanoria S,
Cheng J, Lu J and Ding Y: Effects of genetic variations on
microRNA: Target interactions. Nucleic Acids Res. 42:9543–9552.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Packer LM, Williams SJ, Callaghan S,
Gotley DC and McGuckin MA: Expression of the cell surface mucin
gene family in adenocarcinomas. Int J Oncol. 25:1119–1126.
2004.PubMed/NCBI
|
|
33
|
Lauriola M, Ugolini G, Rosati G, Zanotti
S, Montroni I, Manaresi A, Zattoni D, Rivetti S, Mattei G, Coppola
D, et al: Identification by a digital gene expression displayer
(DGED) and test by RT-PCR analysis of new mRNA candidate markers
for colorectal cancer in peripheral blood. Int J Oncol. 37:519–525.
2010.PubMed/NCBI
|
|
34
|
Settleman J: Predicting response to HER2
kinase inhibition. Oncotarget. 6:588–589. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Chaturvedi P, Singh AP, Chakraborty S,
Chauhan SC, Bafna S, Meza JL, Singh PK, Hollingsworth MA, Mehta PP
and Batra SK: MUC4 mucin interacts with and stabilizes the HER2
oncoprotein in human pancreatic cancer cells. Cancer Res.
68:2065–2070. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Senapati S, Das S and Batra SK:
Mucin-interacting proteins: From function to therapeutics. Trends
Biochem Sci. 35:236–245. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Duan Y, Naruse T, Nakamura M, Yamaguchi Y,
Kawashima T, Morikawa Y, Kitamura T and Suda T: Expression and
functional analysis of a hemopoietic progenitor antigen, NJ-1
(114/A10), in the megakaryocytic lineage. Biochem Biophys Res
Commun. 253:401–406. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhu J, Xu Y, Liu S, Qiao L, Sun J and Zhao
Q: MicroRNAs associated with colon cancer: New potential prognostic
markers and targets for therapy. Front Bioeng Biotechnol.
8:1762020. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Detassis S, Grasso M, Del Vescovo V and
Denti MA: microRNAs make the call in cancer personalized medicine.
Front Cell Dev Biol. 5:862017. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Falzone L, Scola L, Zanghi A, Biondi A, Di
Cataldo A, Libra M and Candido S: Integrated analysis of colorectal
cancer microRNA datasets: Identification of microRNAs associated
with tumor development. Aging (Albany NY). 10:1000–1014. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Pidíková P and Herichová I: miRNA clusters
with up-regulated expression in colorectal cancer. Cancers (Basel).
13:29792021. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Wang X, Gao G, Chen Z, Chen Z, Han M, Xie
X, Jin Q, Du H, Cao Z and Zhang H: Identification of the miRNA
signature and key genes in colorectal cancer lymph node metastasis.
Cancer Cell Int. 21:3582021. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Rupaimoole R and Slack FJ: MicroRNA
therapeutics: Towards a new era for the management of cancer and
other diseases. Nat Rev Drug Discov. 16:203–222. 2017. View Article : Google Scholar : PubMed/NCBI
|
